The apparent selection for replacement mutations in IGHV subregions that differ from those targeted by AID suggest that CLL cells when diversifying in an altered tissue microenvironment might employ a different mutational mechanism with distinct target sites. Here, AICDA is linked to B-cell chronic lymphocytic leukemia.